Luye Pharma Group Ltd. - Laporan Laba Rugi (TTM)

Luye Pharma Group Ltd.
DE ˙ DB ˙ BMG570071099
€ 0.41 ↑0.01 (3.52%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Luye Pharma Group Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 5,864 5,540 5,534 5,529 5,365 5,200 5,150 5,099 5,541 5,982 6,008 6,035 6,089 6,143 6,228 6,314 6,187 6,061 6,115 6,168
Change (%) -5.54 -0.10 -0.10 -2.97 -3.07 -0.97 -0.98 8.65 7.96 0.45 0.44 0.90 0.89 1.39 1.37 -2.00 -2.04 0.88 0.87
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,547 1,549 1,666 1,783 1,793 1,803 1,705 1,606 1,724 1,841 1,921 2,001 1,970 1,939 1,957 1,974 1,996 2,017 2,031 2,045
Change (%) 0.16 7.54 7.01 0.58 0.58 -5.47 -5.78 7.31 6.81 4.35 4.16 -1.56 -1.58 0.91 0.90 1.09 1.08 0.68 0.68
% of Revenue 26.37 27.96 30.10 32.24 33.42 34.68 33.11 31.50 31.11 30.78 31.97 33.16 32.35 31.56 31.41 31.27 32.25 33.28 33.21 33.15
Gross Operating Profit 4,318 3,991 3,869 3,746 3,572 3,397 3,445 3,493 3,817 4,141 4,087 4,034 4,119 4,204 4,272 4,339 4,192 4,044 4,084 4,123
Change (%) -7.58 -3.06 -3.16 -4.67 -4.90 1.42 1.40 9.27 8.48 -1.29 -1.31 2.11 2.07 1.61 1.58 -3.40 -3.52 0.98 0.97
% of Revenue 73.63 72.04 69.90 67.76 66.58 65.32 66.89 68.50 68.89 69.22 68.03 66.84 67.65 68.44 68.59 68.73 67.75 66.72 66.79 66.85
SG&A 2,302 2,185 2,151 2,116 2,196 2,276 2,301 2,327 2,365 2,403 2,557 2,711 2,705 2,700 2,564 2,428 2,413 2,398 2,496 2,593
Change (%) -5.07 -1.59 -1.61 3.77 3.63 1.14 1.12 1.62 1.59 6.42 6.03 -0.20 -0.20 -5.05 -5.32 -0.60 -0.60 4.05 3.89
% of Revenue 39.25 39.45 38.86 38.27 40.93 43.76 44.69 45.64 42.68 40.17 42.55 44.92 44.43 43.95 41.16 38.45 39.00 39.57 40.81 42.03
R&D
Change (%)
% of Revenue
OpEx 4,608 4,551 4,659 4,767 4,802 4,837 4,824 4,811 5,002 5,193 5,339 5,486 5,371 5,256 5,142 5,029 4,977 4,925 5,051 5,178
Change (%) -1.22 2.37 2.32 0.73 0.72 -0.27 -0.27 3.97 3.81 2.82 2.75 -2.10 -2.14 -2.16 -2.21 -1.03 -1.04 2.57 2.50
% of Revenue 78.57 82.16 84.19 86.22 89.51 93.01 93.67 94.34 90.28 86.81 88.86 90.90 88.20 85.55 82.56 79.65 80.43 81.25 82.61 83.95
Operating Income 1,257 988 875 762 563 363 326 288 539 789 669 549 718 887 1,086 1,285 1,211 1,137 1,063 990
Change (%) -21.35 -11.47 -12.95 -26.15 -35.40 -10.31 -11.50 86.79 46.46 -15.21 -17.93 30.81 23.55 22.40 18.30 -5.78 -6.13 -6.45 -6.89
% of Revenue 21.43 17.84 15.81 13.78 10.49 6.99 6.33 5.66 9.72 13.19 11.14 9.10 11.80 14.45 17.44 20.35 19.57 18.75 17.39 16.05
Interest Expense -411 -424 -411 -397 -398 -399 -409 -418 -445 -472 -518 -564 -620 -675 -661 -646 -604 -562 -592 -622
Change (%) 3.19 -3.18 -3.29 0.31 0.31 2.27 2.22 6.49 6.09 9.83 8.95 9.83 8.95 -2.15 -2.19 -6.55 -7.01 5.40 5.12
% of Revenue -7.01 -7.65 -7.42 -7.18 -7.42 -7.68 -7.93 -8.19 -8.03 -7.89 -8.62 -9.35 -10.18 -11.00 -10.61 -10.24 -9.76 -9.27 -9.68 -10.09
Net Income 955 707 630 554 210 -134 -179 -224 190 605 531 458 495 533 652 770 621 472 434 397
Change (%) -26.05 -10.81 -12.13 -62.13 -164.09 33.33 25.00 -185.01 217.63 -12.15 -13.84 8.17 7.55 22.33 18.25 -19.38 -24.03 -7.94 -8.63
% of Revenue 16.29 12.76 11.39 10.02 3.91 -2.58 -3.48 -4.39 3.44 10.11 8.84 7.59 8.13 8.67 10.46 12.20 10.04 7.79 7.10 6.44

Source: Capital IQ

Other Listings
US:LYPHF
HK:2186 HK$ 3.79
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista